Molecular level understanding of resistance to nalidixic acid in Salmonella enteric serovar typhimurium associates with the S83F sequence type

European Biophysics Journal : EBJ
B Preethi, K Ramanathan

Abstract

Nalidixic acid is an antibiotic drug used for treatment of Salmonellosis, a gastrointestinal infection. DNA gyrase subunit A (GyrA) of Salmonella typhimurium is the drug target for nalidixic acid. Resistance of GyrA to nalidixic acid, because of a point mutation in S. typhimurium, was recently reported. Substitution of Phe in place of Ser at locus 83 in GyrA of S. typhimurium has been experimentally associated with nalidixic acid resistance. Despite recent efforts, the mechanism of this resistance is not well understood. In this investigation we used computational techniques to address this shortcoming. Our results showed that contact with residue Arg 91 is certainly important for efficient binding of nalidixic acid to the target protein, and that mutation of this residue results in 180° rotation of the antibiotic in its binding pocket, around its own long axis. It is hoped these findings may enable development of new antibiotics against resistant forms of Salmonella.

References

Dec 18, 1991·European Journal of Biochemistry·R Jaenicke
Oct 1, 1996·Antimicrobial Agents and Chemotherapy·X S PanL M Fisher
Dec 11, 1999·Nucleic Acids Research·H M BermanP E Bourne
Feb 13, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J OteoJ L Gómez-Garcés
Jul 4, 2001·Veterinary Research·A Cloeckaert, E Chaslus-Dancla
Oct 31, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J RobertV Jarlier
May 15, 2002·FEMS Microbiology Reviews·Laura J V Piddock
Jul 24, 2004·Acta Crystallographica. Section D, Biological Crystallography·Alexander W Schüttelkopf, Daan M F van Aalten
Nov 3, 2004·Proteins·Kristin L Meagher, Heather A Carlson
Apr 12, 2005·The FEBS Journal·Sathyapriya Rajagopal, Saraswathi Vishveshwara
Jun 28, 2005·Nucleic Acids Research·Emidio CapriottiRita Casadio
Oct 8, 2005·Journal of Computational Chemistry·David Van Der SpoelHerman J C Berendsen
Dec 31, 2005·Nucleic Acids Research·David S WishartJennifer Woolsey
May 24, 2006·Microbes and Infection·Geovana Brenner MichaelStefan Schwarz
Sep 12, 2007·Bioinformatics·M A LarkinD G Higgins
Nov 11, 2008·Biochemical and Biophysical Research Communications·Ri-Bo HuangKuo-Chen Chou
Feb 20, 2009·Journal of Virology·Zejun LiYoshihiro Kawaoka
Apr 29, 2009·Journal of Computational Chemistry·Garrett M MorrisArthur J Olson
Dec 18, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John A Crump, Eric D Mintz
Feb 18, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shannon E MajowiczUNKNOWN International Collaboration on Enteric Disease 'Burden of Illness' Studies
Mar 23, 2010·The Journal of Antimicrobial Chemotherapy·Laura J V PiddockSimon Gibbons
Jul 1, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G A MenezesJ P Hays
Sep 17, 2011·Journal of Chemical Information and Modeling·Roman A Laskowski, Mark B Swindells
Apr 24, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R-J HassingP J van Genderen
Oct 18, 2013·Molecular Biology and Evolution·Koichiro TamuraSudhir Kumar
Jan 31, 2014·Frontiers in Microbiology·Sylvie BaucheronAxel Cloeckaert
Aug 27, 2014·Proceedings of the National Academy of Sciences of the United States of America·Ravinder AbrolChristopher Irons
Mar 1, 2008·Journal of Chemical Theory and Computation·Berk HessErik Lindahl
Apr 1, 2012·WHO South-East Asia Journal of Public Health·Sangeeta Joshi

❮ Previous
Next ❯

Citations

Oct 24, 2017·Journal of Cellular Biochemistry·Preethi BalasundaramRamanathan Karuppasamy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.